Naltrexone and Scopolamine Rapidly Reduce Symptoms of Major Depressive Disorder (MDD): A Double Blinded Randomized Controlled Pilot Study


Category: General

Type: Article

Date: Jan 2019

Author: N. Taub

This pilot study examined the efficacy of the LDN and Scopolamine in combination for major depression. A robust and rapid reduction was demonstrated in a majority of depressed subjects with a tolerable side effect profile.

Not Finding What You're Looking For?

Fill out the form below to let us know.